Regulatory Consultation

Arbelos anticipates future regulatory challenges and proactively assists clients in transitioning their LDTs to IVDs, streamlining the process and accelerating time-to-market

Arbelos offer the regulatory support

02

FDA Submission type plan

FDA 510K
PMA
Q-Submission
  • De novo
  • Breakthrough program
  • Safer Technologies Program (STeP)
  • Besides companion diagnostic products, our expert also specialize in FDA submission for point of care (POC) device and products.

    Contact experts for first free regulation analysis on your product: Service@arbelosdx.com